ReleaseWire Connect

Online mercury analyzers are the most convenient way to continuously measure the consistency of mercury in dynamic systems such as the environment and industrial plants. As mercury has the ability to adsorb onto most surfaces, each application has its own particular sampling requirements. Factors of mercury analyzer such as ease of use, convenience, and reliability drive the market, along with rapid advances in science & technology, cost efficient mercury detection, and the growth rate of scientific experiments that create plenty of future opportunities for the mercury analyzer market.

Vaccines used currently are composed of killed pathogen or live attenuated viruses, whereas DNA vaccines consist of the DNA sequence of the antigen, which is administered in humans to stimulate an immune response. This approach offers a number of potential advantages over traditional approaches, including the stimulation of both B- and T-cell responses, improved vaccine stability, the absence of any infectious agent, and the relative ease of large-scale manufacture. In addition, DNA vaccines are temperature stable, leading to easier storage and transport.

Travelling to places and facilities, such as hospitals, clinics, wellness SPAs, fitness centers, and wellness resorts to enrich the mental as well as physical health is a part of the lifestyle of the people, now-a-days. This shift in choice refers makes way for wellness tourism, which involves the promotion of health and personal well-being through various physical, psychological, and spiritual activities. It also includes various services such as transport, lodging, food & beverage, shopping, and others.

The global seafood market was valued at $120,848 million in 2016, and is expected to reach $155,316 million by 2023, registering a CAGR of 3.6% from 2017 to 2023, according to the new report published by Allied Market Research. Asia-Pacific dominated the global market accounting for over two-thirds of the total market share in 2016.

Distributed Control Systems (DCS) Market report, published by Allied Market Research, forecasts that the global market is expected to garner $24,609 million by 2022, growing at a CAGR of 5.2% during the period 2016 - 2022. Factors such as increase in demand in power and energy sectors, emergence of open source DCS solutions, and cost & time effectiveness drive the global market. Asia-Pacific is expected be the largest market for DCS during the forecast period.

The IVIG products gained significant attention in the recent years due to their high efficacy in the treatment of immune diseases. Prevalence of various antibody deficiency disorders such as common variable immune deficiency (CVID), specific antibody deficiency, and hypogammaglobulinemia, increase in IVIG indications, improved production & purification processes, growth in awareness towards antibody deficiency, and rare immune disorders among patient population drive the growth of the IVIG market.

Coal is an essential fuel utilized globally to generate electricity, while petroleum fuels are commonly utilized in vehicles. Moreover, coal and petroleum fuels majorly possess carbon (carbon-carbon bond (C-C)) hydrocarbons), which makes the conversion of coal to liquid fuel more feasible. The production of liquid fuel from coal is also known as coal-to-liquid (CTL) technology or coal liquefaction, either by direct or indirect liquefaction. In this procedure, coal is dissolved in a solvent at high temperature and pressure, followed by hydrogenation to produce a high-grade, clean fuel suitable for use in transport. Moreover, the obtained liquid fuel tends to be ultra-clean, sulfur-free, low in particulates, causes low CO2, oxides, and nitrogen emissions through Carbon Capture and Storage (CCS).

The global frozen food packaging market was valued at $33,231 million in 2016, and is projected to reach $47,376 million by 2023, registering a CAGR of 5.3% from 2017 to 2023. In 2016, boxes type segment accounted for approximately one-third share of the global market in terms of revenue.

Global Orphan Drugs Market is expected to garner $169 billion from $106 billion and register a CAGR of 6.8% during the forecast period, 2016-2022. Orphan drug can be defined as a pharmaceutical agent specifically designed to treat rare (orphaned) diseases. These diseases differ from usual diseases as their prevalence rate is very low and hence appeal to a very small patient population. Therefore, as compared to non-orphan drugs, these drugs do not guarantee feasible returns on investment. However, various government authorities encourage to develop and market such drugs. Cost associated with the development of these drugs is higher when compared with non-orphan drugs. The different indications for which orphan drugs are used include lymphoma, leukemia, cystic fibrosis, and others.

The number of patients living with the diabetes worldwide is expected to soar from 371 million in 2012 to 552 million by 2030. This suggests that by 2030, there will be 3 new cases of diabetes every 10 seconds. "The rampant growth of diabetes and obesity has prompted pharmaceutical manufacturers to seek out novel pharmaceutical solutions to tap promising potential in NASH," states AMR analyst Roshan Deshmukh. "Instrumental initiatives and increasing clinical trials for the development of novel NASH therapeutics will steer its faster commercialization," adds the analyst. Concerted efforts in research and development for companies such as Genfit, Gilead Science, Novo Nordisk, Raptor Pharmaceutical Corp. and Intercepts Pharmaceuticals would help them gain core competencies in this market.